The role of voltage gated T-type Ca2+ channel isoforms in mediating "capacitative" Ca2+ entry in cancer cells

Area of Science:

• Molecular Biology
• Pharmacology
• Oncology

Background:

• The mechanism of calcium (Ca2+) entry into electrically non-excitable cells remains largely unknown.
• Extracellular Ni2+ sensitivity of Ca2+ entry pathways was previously observed in these cells.

Purpose of the Study:

• To synthesize novel compounds targeting Ca2+ entry pathways in non-excitable cells.
• To investigate the effect of these compounds on cancer cell proliferation and Ca2+ influx.
• To identify the specific calcium channel isoforms involved in mediating these effects.

Main Methods:

• Synthesis of novel compounds based on Ni2+ inhibition sensitivity of Ca2+ entry.
• Assay of compound effects on cancer cell line proliferation and Ca2+ influx.
• Stereoselective inhibition studies on heterologously expressed Cav3.2 T-type Ca2+ channels.
• Analysis of Cav3.2 and its splice variants in sensitive and resistant cancer cell lines.

Main Results:

• Novel compounds were found to inhibit Ca2+ entry and proliferation in multiple cancer cell lines.
• Inhibition of proliferation and Ca2+ influx was stereoselective, mirroring Cav3.2 T-type Ca2+ channel inhibition.
• Cancer cell lines expressing Cav3.2 or its delta25B splice variant were sensitive to the compounds.

Conclusions:

• The Cav3.2 T-type Ca2+ channel is a key mediator of Ca2+ entry and proliferation in sensitive cancer cells.
• Novel compounds targeting Cav3.2 channels show potential for cancer treatment.
• These findings suggest a new therapeutic strategy based on blocking specific calcium channels.